Overview

Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding

Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The overall study purpose is to evaluate the safety, feasibility and acceptability of advance distribution of misoprostol to be used as 'first aid treatment' administered by the woman herself or her family to help treat excessive bleeding in home births.
Phase:
Phase 4
Details
Lead Sponsor:
Gynuity Health Projects
Collaborator:
National Committee for Maternal & Neonatal Health
Treatments:
Misoprostol